Marco Presta Selected Research

Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)

5/2021	Caffeine Inhibits Direct and Indirect Angiogenesis in Zebrafish Embryos.
9/2019	PTX3 Modulates Neovascularization and Immune Inflammatory Infiltrate in a Murine Model of Fibrosarcoma.
1/2018	Long Pentraxin-3 Modulates the Angiogenic Activity of Fibroblast Growth Factor-2.
1/2018	Long Pentraxin 3-Mediated Fibroblast Growth Factor Trapping Impairs Fibrosarcoma Growth.
10/2017	Fibroblast growth factor modulates mast cell recruitment in a murine model of prostate cancer.
8/2015	Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer Therapy.
5/2015	A long pentraxin-3-derived pentapeptide for the therapy of FGF8b-driven steroid hormone-regulated cancers.
3/2015	The broad-spectrum anti-DNA virus agent cidofovir inhibits lung metastasis of virus-independent, FGF2-driven tumors.
12/2013	Long pentraxin-3 inhibits epithelial-mesenchymal transition in melanoma cells.
6/2013	Long pentraxin-3 as an epithelial-stromal fibroblast growth factor-targeting inhibitor in prostate cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marco Presta Research Topics

Disease

69	Neoplasms (Cancer) 01/2022 - 02/2002
12	Inflammation (Inflammations) 09/2019 - 06/2002
7	Diabetic Retinopathy (Retinopathy, Diabetic) 02/2021 - 07/2014
6	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 06/2013
6	Multiple Myeloma 05/2021 - 01/2013
5	Globoid Cell Leukodystrophy (Krabbe Disease) 12/2019 - 09/2013
4	Retinal Neovascularization 02/2021 - 07/2013
4	Melanoma (Melanoma, Malignant) 01/2021 - 12/2013
4	Neoplasm Metastasis (Metastasis) 01/2021 - 06/2002
3	Hypoxia (Hypoxemia) 01/2020 - 03/2010
3	Adenocarcinoma 10/2017 - 06/2003
3	Breast Neoplasms (Breast Cancer) 07/2017 - 09/2011
3	Carcinoma (Carcinomatosis) 05/2015 - 11/2005
3	Acquired Immunodeficiency Syndrome (AIDS) 01/2005 - 01/2002
2	Fibrosis (Cirrhosis) 01/2022 - 01/2021
2	Pathologic Processes 01/2022 - 08/2002
2	Epiretinal Membrane (Epiretinal Membranes) 10/2021 - 12/2020
2	Wounds and Injuries (Trauma) 01/2021 - 07/2007
2	Fibrosarcoma 09/2019 - 01/2018
2	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2016 - 04/2014
2	Vascular Diseases (Vascular Disease) 01/2016 - 07/2007
2	Pathologic Neovascularization 06/2015 - 09/2012
2	Experimental Melanoma 03/2010 - 12/2008
1	Cicatrix (Scar) 02/2021
1	Gliosis 02/2021
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2021
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2021
1	Hematologic Neoplasms (Hematological Malignancy) 01/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2020
1	Lung Neoplasms (Lung Cancer) 12/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2020
1	Skin Neoplasms (Skin Cancer) 11/2020
1	Nevus (Nevi) 11/2020
1	Sphingolipidoses (Sphingolipidosis) 12/2019

Drug/Important Bio-Agent (IBA)

20	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 05/2021 - 06/2003
19	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2021 - 02/2002
18	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2021 - 06/2003
12	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2021 - 04/2005
11	PTX3 proteinIBA 05/2021 - 09/2005
10	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2002
9	LigandsIBA 01/2022 - 12/2009
8	Biological ProductsIBA 01/2022 - 01/2005
8	GalactosylceramidaseIBA 01/2022 - 09/2013
8	CytokinesIBA 02/2021 - 07/2003
7	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022 - 06/2003
5	Psychosine (Galactosylsphingosine)IBA 01/2022 - 09/2013
5	Retinaldehyde (Retinal)IBA 10/2021 - 07/2014
5	ChemokinesIBA 02/2021 - 04/2005
5	Tyrosine Kinase InhibitorsIBA 01/2021 - 04/2007
5	Pattern Recognition ReceptorsIBA 01/2018 - 07/2004
4	EnzymesIBA 01/2022 - 09/2013
4	Extracellular Matrix ProteinsIBA 10/2021 - 07/2003
4	Pharmaceutical PreparationsIBA 01/2021 - 01/2007
4	Angiogenesis InhibitorsIBA 01/2018 - 01/2007
3	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2022 - 04/2007
3	Heparin (Liquaemin)FDA LinkGeneric 01/2022 - 01/2005
3	AndrogensIBA 01/2022 - 09/2011
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2021 - 12/2009
3	MorpholinosIBA 09/2012 - 01/2007
2	enzalutamideIBA 01/2022 - 01/2020
2	SphingolipidsIBA 11/2021 - 11/2020
2	OligosaccharidesIBA 01/2016 - 11/2005
2	SteroidsIBA 05/2015 - 09/2011
2	Hormones (Hormone)IBA 05/2015 - 09/2011
2	AntibodiesIBA 01/2015 - 01/2009
2	Peptides (Polypeptides)IBA 11/2014 - 03/2010
2	Dihydrotestosterone (Androstanolone)IBA 06/2013 - 09/2011
2	Antineoplastic Agents (Antineoplastics)IBA 09/2011 - 01/2005
2	matrigelIBA 12/2010 - 02/2005
2	Tetracycline (Achromycin)FDA LinkGeneric 12/2009 - 06/2003
2	Complementary DNA (cDNA)IBA 12/2009 - 06/2003
2	OsteopontinIBA 07/2007 - 07/2003
1	Cystine (L-Cystine)IBA 01/2022
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 01/2022
1	pemigatinibIBA 01/2022
1	Antisense OligonucleotidesIBA 11/2021
1	Protein Isoforms (Isoforms)IBA 11/2021
1	CollagenIBA 01/2021
1	linifanibIBA 01/2021
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2021
1	GlutaminaseIBA 01/2021
1	Glutamine (L-Glutamine)FDA Link 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Viral ProteinsIBA 01/2021
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 01/2021
1	erdafitinibIBA 12/2020
1	Monophenol Monooxygenase (Tyrosinase)IBA 11/2020
1	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 11/2020
1	CeramidesIBA 11/2020
1	Microphthalmia-Associated Transcription FactorIBA 11/2020
1	CatalaseIBA 01/2020
1	macitentanIBA 01/2020
1	Bortezomib (Velcade)FDA Link 01/2020
1	Endothelin-1 (Endothelin 1)IBA 01/2020
1	Androgen Receptor AntagonistsIBA 01/2020
1	AntioxidantsIBA 01/2020
1	Vitamin E FDA LinkGeneric 01/2020

Therapy/Procedure

29	Therapeutics 01/2022 - 04/2002
2	Castration 01/2022 - 01/2020
1	Drug Therapy (Chemotherapy) 01/2020